VMD - Viemed Healthcare Inc Stock Price, Fair Value and News

7.10USD+0.03 (+0.42%)Delayed

Market Summary

USD7.10+0.03

Delayed

0.42%

VMD Alerts

Big jump in Revenue (Y/Y)

VMD Stock Price

View Fullscreen

VMD RSI Chart

VMD Valuation

Market Cap

275.6M

Price/Earnings (Trailing)

26.68

Price/Sales (Trailing)

1.42

EV/EBITDA

21.81

Price/Free Cashflow

32.53

VMD Price/Sales (Trailing)

VMD Profitability

EBT Margin

7.47%

Return on Equity

8.88%

Return on Assets

6.67%

Free Cashflow Yield

3.07%

VMD Fundamentals

VMD Revenue

Revenue (TTM)

194.0M

Rev. Growth (Yr)

27.9%

Rev. Growth (Qtr)

-0.29%

VMD Earnings

Earnings (TTM)

10.3M

Earnings Growth (Yr)

5.67%

Earnings Growth (Qtr)

-53.9%

Breaking Down VMD Revenue

Last 7 days

-0.6%

Last 30 days

-9.2%

Last 90 days

-18.0%

Trailing 12 Months

-30.9%

How does VMD drawdown profile look like?

VMD Financial Health

Current Ratio

1.28

Debt/Equity

0.05

Debt/Cashflow

6.08

VMD Investor Care

Shares Dilution (1Y)

1.42%

Diluted EPS (TTM)

0.25

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	194.0M	0	0	0
2023	146.1M	156.1M	169.8M	183.0M
2022	120.9M	126.8M	133.3M	138.8M
2021	135.9M	120.5M	116.3M	117.1M
2020	85.9M	108.5M	121.6M	131.3M
2019	68.6M	73.7M	77.2M	80.3M
2018	0	0	0	64.5M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Viemed Healthcare Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 22, 2024	hoyt casey	gifted	-	-	-26,000	chief executive officer
Jan 18, 2024	hoyt casey	back to issuer	-107,549	7.62	-14,114	chief executive officer
Jan 18, 2024	hoyt casey	acquired	-	-	28,228	chief executive officer
Jan 18, 2024	cambre jerome	back to issuer	-22,882	7.62	-3,003	vice president of sales
Jan 18, 2024	hoyt casey	acquired	-	-	14,114	chief executive officer
Jan 18, 2024	fitzgerald trae	acquired	-	-	5,406	chief financial officer
Jan 18, 2024	zehnder william todd	acquired	-	-	9,490	chief operating officer
Jan 18, 2024	moore michael	acquired	-	-	18,979	president
Jan 18, 2024	zehnder william todd	back to issuer	-72,313	7.62	-9,490	chief operating officer
Jan 18, 2024	moore michael	acquired	-	-	9,490	president

Which funds bought or sold VMD recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-38.92	-11,745	32,364	-%
May 16, 2024	JANE STREET GROUP, LLC	added	69.93	137,526	269,594	-%
May 16, 2024	AWM Investment Company, Inc.	unchanged	-	2,259,940	13,488,200	1.77%
May 15, 2024	BANK OF AMERICA CORP /DE/	reduced	-38.39	-100,235	285,436	-%
May 15, 2024	MILLENNIUM MANAGEMENT LLC	reduced	-77.81	-842,112	304,957	-%
May 15, 2024	BARCLAYS PLC	reduced	-48.8	-143,000	229,000	-%
May 15, 2024	Sage Rock Capital Management LP	reduced	-29.52	-63,215	348,910	1.42%
May 15, 2024	DEUTSCHE BANK AG\	added	2.51	38,952	207,272	-%
May 15, 2024	STATE STREET CORP	added	31.27	2,082,050	5,691,340	-%
May 15, 2024	PRICE T ROWE ASSOCIATES INC /MD/	new	-	97,000	97,000	-%

Are Funds Buying or Selling VMD?

Are funds buying VMD calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own VMD

No. of Funds

VMD Alerts

Big jump in Revenue (Y/Y)

Unveiling Viemed Healthcare Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 15, 2024	hoyt casey	8.0%	3,116,189	SC 13G/A
Feb 15, 2024	moore michael	6.5%	2,520,918	SC 13D/A
Feb 14, 2024	nantahala capital management, llc	5.1%	1,952,368	SC 13G
Feb 13, 2024	thrivent financial for lutherans	8.7%	3,347,784	SC 13G/A
Feb 02, 2024	blackrock inc.	5.6%	2,129,167	SC 13G
May 18, 2023	moore michael	6.3%	2,421,319	SC 13D/A
Feb 21, 2023	viemed healthcare, inc.	7.6%	2,973,243	SC 13G/A
Feb 08, 2023	thrivent financial for lutherans	10.88%	4,134,751	SC 13G/A
Oct 18, 2022	thrivent financial for lutherans	10.1%	3,855,125	SC 13G/A
Jul 08, 2022	blackrock inc.	2.4%	967,193	SC 13G

Recent SEC filings of Viemed Healthcare Inc

View All Filings

Date Filed	Form Type	Document
May 14, 2024	4	Insider Trading
May 10, 2024	4	Insider Trading
May 10, 2024	4	Insider Trading
May 10, 2024	4	Insider Trading
May 10, 2024	4	Insider Trading
May 10, 2024	4	Insider Trading
May 09, 2024	8-K	Current Report
May 06, 2024	10-Q	Quarterly Report
May 06, 2024	8-K	Current Report
Apr 26, 2024	DEF 14A	DEF 14A

Peers (Alternatives to Viemed Healthcare Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	181.0B	40.3B	-1.75%	-4.07%	32.18	4.49	-2.84%	-3.08%
BDX	68.3B	19.7B	1.78%	-6.05%	51.24	3.46	4.82%	-17.56%
ALGN	20.4B	3.9B	-9.57%	-7.50%	44.2	5.22	5.72%	46.72%
BAX	18.0B	14.9B	-10.73%	-18.01%	6.79	1.21	2.98%	207.68%
MID-CAP
ATR	9.8B	3.5B	6.68%	24.08%	31.27	2.76	6.16%	35.06%
HSIC	9.6B	12.5B	6.31%	-2.51%	24.63	0.77	-0.61%	-18.83%
BIO	8.4B	2.6B	1.13%	-22.65%	-26.02	3.22	-6.25%	-68.62%
XRAY	5.9B	3.9B	-6.79%	-30.12%	-62.84	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	0.52%	31.17%	-216.3	8.9	30.82%	65.57%
PDCO	2.3B	6.6B	0.19%	-5.50%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	5.94%	-10.00%	-1.91	0.41	7.94%	-1661.78%
ANIK	376.6M	169.3M	-1.13%	-2.23%	-4.9	2.23	7.49%	-244.90%
ANGO	241.9M	324.0M	-4.58%	-37.15%	-1.26	0.75	-3.19%	-337.41%
APYX	56.1M	50.5M	22.73%	-73.49%	-2.46	1.11	14.25%	-10.06%
AEMD	1.0M	3.7M	-71.83%	-87.10%	-0.09	0.28	5.77%	8.23%

Viemed Healthcare Inc News

Latest updates

Viemed Healthcare Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-0.3%	50,593	50,739	49,402	43,311	39,556	37,508	35,759	33,310	32,255	31,962	29,285	27,399	28,416	31,202	33,447	42,854	23,806	21,448	20,368	20,325	18,115
Gross Profit	-7.2%	29,802	32,111	30,562	26,106	24,004	22,896	21,651	20,390	19,743	19,662	18,381	17,625	17,742	19,178	19,453	25,927	15,553	14,243	14,050	14,639	13,074
S&GA Expenses	3.8%	24,814	23,905	23,654	20,563	19,762	17,172	17,677	17,536	15,776	14,240	13,260	12,884	14,509	12,274	13,550	16,428	10,577	10,174	10,231	11,516	9,460
R&D Expenses	15.2%	750	651	593	758	780	722	670	672	632	612	576	583	339	395	243	271	174	203	208	203	234
EBITDA Margin	-28.7%	0.06*	0.09*	0.11*	0.09*	0.08*	0.07*	0.19*	0.20*	0.21*	0.21*	0.21*	0.20*	-	-	-	-	-	-	-	-	-
Interest Expenses	-36.7%	224	354	328	127	42.00	46.00	57.00	62.00	66.00	73.00	80.00	81.00	117	122	128	144	165	242	39.00	26.00	26.00
Income Taxes	-69.2%	500	1,624	1,320	728	500	1,146	456	421	745	968	1,386	1,246	-223	151	1,141	-6,646	187	58.00	51.00	24.00	138
Earnings Before Taxes	-58.2%	2,121	5,076	4,239	3,058	2,018	3,584	1,511	1,388	2,507	5,055	3,175	2,812	1,461	5,222	3,945	12,766	4,430	2,446	2,904	1,350	2,096
EBT Margin	-5.0%	0.07*	0.08*	0.08*	0.07*	0.06*	0.06*	0.08*	0.10*	0.11*	0.11*	0.11*	0.11*	-	-	-	-	-	-	-	-	-
Net Income	-53.9%	1,603	3,477	2,919	2,330	1,517	2,438	1,055	967	1,762	4,087	1,789	1,566	1,684	5,071	2,804	19,412	4,243	2,388	2,853	1,326	1,958
Net Income Margin	-4.9%	0.05*	0.06*	0.05*	0.05*	0.04*	0.04*	0.06*	0.07*	0.08*	0.08*	0.09*	0.09*	-	-	-	-	-	-	-	-	-
Free Cashflow	-190.3%	-4,831	5,352	6,407	1,545	5,815	2,112	1,635	-2,080	3,183	1,992	-3,005	933	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	0.0%	155	155	149	149	125	117	119	116	119	118	115	111	113	113	114	112	87.00	83.00	80.00	71.00	59.00
Current Assets	0.7%	39.00	38.00	36.00	36.00	47.00	40.00	43.00	42.00	48.00	47.00	47.00	47.00	48.00	47.00	50.00	49.00	30.00	28.00	28.00	25.00	24.00
Cash Equivalents	-43.1%	7.00	13.00	10.00	10.00	24.00	17.00	21.00	22.00	29.00	28.00	27.00	31.00	31.00	31.00	32.00	30.00	8.00	13.00	13.00	8.00	7.00
Inventory	-6.0%	4.00	5.00	5.00	4.00	3.00	4.00	3.00	3.00	3.00	2.00	3.00	3.00	2.00	2.00	3.00	7.00	2.00	1.00	1.00	4.00	4.00
Net PPE	-0.1%	74.00	74.00	73.00	73.00	68.00	68.00	-	-	64.00	63.00	59.00	54.00	54.00	55.00	56.00	55.00	57.00	55.00	52.00	46.00	35.00
Goodwill	0%	30.00	30.00	30.00	30.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Liabilities	-5.8%	39.00	41.00	41.00	45.00	25.00	20.00	26.00	23.00	23.00	23.00	26.00	25.00	30.00	31.00	39.00	41.00	38.00	39.00	40.00	35.00	25.00
Current Liabilities	-6.2%	30.00	32.00	32.00	32.00	23.00	19.00	21.00	18.00	18.00	18.00	20.00	18.00	22.00	23.00	30.00	32.00	26.00	26.00	27.00	27.00	22.00
Long Term Debt	-1.6%	6.00	6.00	8.00	12.00	-	-	4.00	4.00	4.00	4.00	4.00	5.00	5.00	6.00	6.00	7.00	7.00	8.00	8.00	5.00	-
LT Debt, Current	-44.4%	1.00	1.00	2.00	3.00	-	-	0.00	1.00	1.00	1.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	0.00	-
LT Debt, Non Current	-100.0%	-	6.00	8.00	12.00	-	-	4.00	4.00	4.00	4.00	4.00	5.00	5.00	6.00	6.00	7.00	7.00	8.00	8.00	5.00	-
Shareholder's Equity	2.1%	116	114	109	105	100	97.00	94.00	93.00	96.00	95.00	89.00	86.00	83.00	82.00	75.00	71.00	49.00	44.00	40.00	36.00	34.00
Retained Earnings	0.8%	80.00	79.00	76.00	73.00	71.00	70.00	68.00	69.00	73.00	73.00	69.00	67.00	66.00	66.00	61.00	58.00	38.00	34.00	32.00	29.00	28.00
Additional Paid-In Capital	-8.9%	14.00	16.00	14.00	13.00	12.00	12.00	11.00	10.00	9.00	8.00	7.00	5.00	4.00	7.00	6.00	5.00	4.00	6.00	5.00	5.00	4.00
Shares Outstanding	0.8%	39.00	39.00	38.00	38.00	38.00	38.00	39.00	39.00	40.00	39.00	40.00	39.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	330	-	-	-	182	-	-	-	251	-	-	-	335	-	-	-	117,224	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-91.2%	1,175	13,284	13,809	7,623	10,496	7,684	7,972	4,946	7,146	8,655	5,028	4,183	4,628	5,791	7,331	21,381	607	7,400	5,724	5,313	650
Share Based Compensation	-6.6%	1,432	1,534	1,453	1,471	1,391	1,317	1,309	1,271	1,305	1,305	1,302	1,236	1,307	1,301	1,234	1,196	1,151	908	1,064	1,034	880
Cashflow From Investing	28.4%	-5,365	-7,493	-8,508	-32,207	-3,905	-7,378	-6,103	-6,688	-3,807	-6,563	-8,425	-3,060	-1,698	-5,368	-2,427	1,091	-1,711	-2,579	-2,745	-7,395	-92.00
Cashflow From Financing	55.8%	-1,340	-3,030	-5,447	11,264	39.00	-4,870	-2,313	-5,584	-2,499	-551	-887	-1,069	-2,814	-1,838	-2,215	-1,174	-3,842	-4,096	1,960	2,363	-3,561
Buy Backs	-	1,000	-	-	-	-	710	1,857	5,114	1,887	-	-	-1,434	1,434	-	-	-	-	-	-	-	1,522

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

VMD Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue	$ 50,593	$ 39,556
Cost of revenue	20,791	15,552
Gross profit	29,802	24,004
Operating expenses
Selling, general and administrative	24,814	19,762
Research and development	750	780
Stock-based compensation	1,432	1,391
Depreciation and amortization	415	240
Loss (gain) on disposal of property and equipment	213	(22)
Other income, net	(26)	(81)
Income from operations	2,204	1,934
Non-operating income and expenses
Income from equity method investments	(67)	(35)
Interest expense (income), net	150	(49)
Net income before taxes	2,121	2,018
Provision for income taxes	518	501
Net income	1,603	1,517
Other comprehensive income	0	0
Comprehensive income	$ 1,603	$ 1,517
Net income per share
Basic (in dollars per share)	$ 0.04	$ 0.04
Diluted (in dollars per share)	$ 0.04	$ 0.04
Weighted average number of common shares outstanding:
Basic (in shares)	38,717,123	38,156,777
Diluted (in shares)	40,580,634	40,016,693

VMD Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 7,309	$ 12,839
Accounts receivable, net	24,477	18,451
Inventory	4,349	4,628
Prepaid expenses and other assets	2,483	2,449
Total current assets	38,618	38,367
Long-term assets
Property and equipment, net	73,511	73,579
Finance lease right-of-use assets	297	401
Operating lease right-of-use assets	2,733	2,872
Equity investments	1,698	1,680
Debt investment	2,274	2,219
Deferred tax asset	4,558	4,558
Identifiable intangibles, net	534	567
Goodwill	29,765	29,765
Other long-term assets	887	887
Total long-term assets	116,257	116,528
TOTAL ASSETS	154,875	154,895
Current liabilities
Trade payables	5,800	4,180
Deferred revenue	6,092	6,207
Income taxes payable	2,675	2,153
Accrued liabilities	14,057	17,578
Finance lease liabilities, current portion	199	256
Operating lease liabilities, current portion	698	678
Current portion of long-term debt	596	1,072
Total current liabilities	30,117	32,124
Long-term liabilities
Accrued liabilities	447	558
Finance lease liabilities, less current portion	95	132
Operating lease liabilities, less current portion	2,037	2,184
Long-term debt	5,906	6,002
Total long-term liabilities	8,485	8,876
TOTAL LIABILITIES	38,602	41,000
Commitments and Contingencies	0	0
SHAREHOLDERS' EQUITY
Common stock - No par value: unlimited authorized; 38,816,766 and 38,506,161 issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	21,842	18,702
Additional paid-in capital	14,294	15,698
Retained earnings	80,137	79,495
TOTAL SHAREHOLDERS' EQUITY	116,273	113,895
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 154,875	$ 154,895

About Viemed Healthcare Inc

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

CEO	Mr. Casey Hoyt
WEBSITE	viemed.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	974

Viemed Healthcare Inc Frequently Asked Questions

What is the ticker symbol for Viemed Healthcare Inc? What does VMD stand for in stocks?

VMD is the stock ticker symbol of Viemed Healthcare Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Viemed Healthcare Inc (VMD)?

As of Fri May 17 2024, market cap of Viemed Healthcare Inc is 275.63 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of VMD stock?

You can check VMD's fair value in chart for subscribers.

What is the fair value of VMD stock?

You can check VMD's fair value in chart for subscribers. The fair value of Viemed Healthcare Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Viemed Healthcare Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for VMD so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Viemed Healthcare Inc a good stock to buy?

The fair value guage provides a quick view whether VMD is over valued or under valued. Whether Viemed Healthcare Inc is cheap or expensive depends on the assumptions which impact Viemed Healthcare Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VMD.

What is Viemed Healthcare Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, VMD's PE ratio (Price to Earnings) is 26.68 and Price to Sales (PS) ratio is 1.42. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. VMD PE ratio will change depending on the future growth rate expectations of investors.